Intratumoral Administration of High-Concentration Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and Survival in CT26 Tumor-Bearing Mice.

Cells · 2023 · PMC10605471 · PMID 37887283

Europe PMC DOI

hedged sentence

0.0653

closest p · 1.3× alpha

0.0653

boldest claim

The sentences

showed a trendp = 0.0653so close (0.05 < p ≤ 0.1)

(7) Combination treatment showed a trend toward increased survival 100 days post-treatment compared to anti-mPD-1 alone ( p = 0.0653).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.